Clinical Trials Browser

Phase 1 × Leukemia × Temozolomide × Clear all

NCT00083070 2014-02-20

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Blast Crisis, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00098436 2013-07-18

Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias

Phase 1 Completed

LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma